CLOSED-LOOP AUTONOMIC NEUROMODULATION FOR OPTIMAL CONTROL OF NEUROLOGICAL AND METABOLIC DISEASE
Patent №
US 7,974,696
Granted
2011-07-05
Filed 2005
Owner
DILORENZO BIOMEDICAL, LLC
Lab
—
AI components
2
ml · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
11187315
A neurological control system for modulating activity of any component or structure of some or all of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” This system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators to control neurological state or autonomic state and prevent neurological or metabolic signs and symptoms. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals, with sensors configured to sense a particular characteristic indicative of a neurological, psychiatric, or metabolic condition.
AI classification
Ownership
DILORENZO BIOMEDICAL, LLC
assignment · 263570039